Jessica Duncan, the chief medical officer for IVIM Health, a for-profit company that prescribes FDA-approved peptides, said she believes that because there is demand for the unapproved therapies, the FDA should work to ensure they can be provided by doctors
This toxic byproduct can wreak havoc on your organs, causing that pounding headache, nausea, sensitivity to light and sound, and overall fatigue we know all too well
Larger studies incorporating standardized dosing regimens are needed to more clearly establish whether NAC is useful as a preventive or treatment agent for these disorders
Important context: These peptides are still NOT FDA-approved But they can now move through formal regulatory review Compounding access may expand again through licensed providers Whats next: July 2026: Formal review begins Late 2026+: Potential decisions on access and compounding pathways For the past two years, limited access pushed demand into unregulated markets
7) Fighting Infections Viral infections flood the body with oxidative stress due to inflammation, using up more glutathione [35]
S2CID 52038817
